These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3097864)

  • 21. Bacterial reservoirs in cystic fibrosis.
    Taylor CJ; McGaw J; Howden R; Duerden BI; Baxter PS
    Arch Dis Child; 1990 Feb; 65(2):175-7. PubMed ID: 2317061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular typing of the bacterial flora in sputum of cystic fibrosis patients.
    Kolak M; Karpati F; Monstein HJ; Jonasson J
    Int J Med Microbiol; 2003 Aug; 293(4):309-17. PubMed ID: 14503795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis.
    Burns JL; Van Dalfsen JM; Shawar RM; Otto KL; Garber RL; Quan JM; Montgomery AB; Albers GM; Ramsey BW; Smith AL
    J Infect Dis; 1999 May; 179(5):1190-6. PubMed ID: 10191222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precipitating Pseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients.
    Trancassini M; de Vito D; Cimino G; Antonelli M; Quattrucci S; Cipriani P
    Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):309-12. PubMed ID: 8781882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients.
    Sajjan US; Tran LT; Sole N; Rovaldi C; Akiyama A; Friden PM; Forstner JF; Rothstein DM
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3437-44. PubMed ID: 11709321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of Staphylococcus aureus from sputum in cystic fibrosis.
    Sparham PD; Lobban DI; Speller DC
    J Clin Pathol; 1978 Oct; 31(10):913-8. PubMed ID: 101553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Aaron SD; Kottachchi D; Ferris WJ; Vandemheen KL; St Denis ML; Plouffe A; Doucette SP; Saginur R; Chan FT; Ramotar K
    Eur Respir J; 2004 Oct; 24(4):631-7. PubMed ID: 15459143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis.
    Valenza G; Tappe D; Turnwald D; Frosch M; König C; Hebestreit H; Abele-Horn M
    J Cyst Fibros; 2008 Mar; 7(2):123-7. PubMed ID: 17693140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis.
    Kolpen M; Hansen CR; Bjarnsholt T; Moser C; Christensen LD; van Gennip M; Ciofu O; Mandsberg L; Kharazmi A; Döring G; Givskov M; Høiby N; Jensen PØ
    Thorax; 2010 Jan; 65(1):57-62. PubMed ID: 19846469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftolozane/tazobactam sensitivity patterns in Pseudomonas aeruginosa isolates recovered from sputum of cystic fibrosis patients.
    Finklea JD; Hollaway R; Lowe K; Lee F; Le J; Jain R
    Diagn Microbiol Infect Dis; 2018 Sep; 92(1):75-77. PubMed ID: 29884565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial flora and ion content of cystic fibrosis sputum.
    Kilbourn JP
    Pediatr Res; 1980 Mar; 14(3):259-60. PubMed ID: 6770327
    [No Abstract]   [Full Text] [Related]  

  • 34. Microbiologic data overview of Italian cystic fibrosis patients.
    Taccetti G; Campana S
    Eur J Epidemiol; 1997 Apr; 13(3):323-7. PubMed ID: 9258532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis.
    Zebouh M; Thomas C; Honderlick P; Lemee L; Segonds C; Wallet F; Husson MO
    J Cyst Fibros; 2008 May; 7(3):238-43. PubMed ID: 18498727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing Incidence of Multidrug Resistance Among Cystic Fibrosis Respiratory Bacterial Isolates.
    Rutter WC; Burgess DR; Burgess DS
    Microb Drug Resist; 2017 Jan; 23(1):51-55. PubMed ID: 27326758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metagenome - Inferred bacterial replication rates in cystic fibrosis airways.
    Pienkowska K; Wiehlmann L; Tümmler B
    J Cyst Fibros; 2019 Sep; 18(5):653-656. PubMed ID: 30685331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum.
    Stutman HR; Akaniro JC; Vidaurre CE; Marks MI
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1366-70. PubMed ID: 2386368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility to various antimicrobial agents and tolerance to methicillin of Staphylococcus aureus isolates from cystic fibrosis patients.
    Horrevorts AM; Mouton JW
    Eur J Clin Microbiol Infect Dis; 1991 Sep; 10(9):785-6. PubMed ID: 1810739
    [No Abstract]   [Full Text] [Related]  

  • 40. Coexistence of Candida species and bacteria in patients with cystic fibrosis.
    Haiko J; Saeedi B; Bagger G; Karpati F; Özenci V
    Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1071-1077. PubMed ID: 30739228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.